ncRNA name
UCA1
Specific or universal ncRNAs
Universal ncRNAs
Class
Long noncoding RNA
Biomarker
Yes
Biomarker application
Treatment
Upstream regulatory factors
Not available
Downstream target
miR-129/ABCB1
Cancer name
Ovarian Cancer
Cancer site
Ovary
Treatment type
Chemotherapy
Drug
Paclitaxel
Impact of wild-type ncRNA on chemotherapy resistance
Up
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
UCA1 confers paclitaxel resistance to ovarian cancer through miR-129/ABCB1.
Tissue resource
human embryonic kidney cell lines HEK-293T
human ovarian cancer cell lines SKOV3
human ovarian cancer cell lines HeyA-8
human ovarian cancer paclitaxel-resistant cell lines SKOV3/PTX
human ovarian cancer paclitaxel-resistant cell lines HeyA-8/PTX
Experiment
qRT-PCR,Western blot,Luciferase reporter assay
Institute
Country
Continent